Phase I study of dasatinib in combination with capecitabine, oxaliplatin, and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

被引：2
|
作者：
Starodub, A.
Cohn, A. L.
Arrowood, C.
Haley, S.
Morse, M.
Uronis, H. E.
Blobe, G. C.
Hsu, S. D.
Zafar, Y.
Hurwitz, H.
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
    Strickler, John H.
    McCall, Shannon
    Nixon, Andrew B.
    Brady, John C.
    Pang, Herbert
    Rushing, Christel
    Cohn, Allen
    Starodub, Alexander
    Arrowood, Christy
    Haley, Sherri
    Meadows, Kellen L.
    Morse, Michael A.
    Uronis, Hope E.
    Blobe, Gerard C.
    Hsu, S. David
    Zafar, S. Yousuf
    Hurwitz, Herbert I.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 330 - 339
  • [2] Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
    John H. Strickler
    Shannon McCall
    Andrew B. Nixon
    John C. Brady
    Herbert Pang
    Christel Rushing
    Allen Cohn
    Alexander Starodub
    Christy Arrowood
    Sherri Haley
    Kellen L. Meadows
    Michael A. Morse
    Hope E. Uronis
    Gerard C. Blobe
    S. David Hsu
    S. Yousuf Zafar
    Herbert I. Hurwitz
    Investigational New Drugs, 2014, 32 : 330 - 339
  • [3] Phase I study of dasatinib in combination with capecitabine, oxaliplatin, and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
    Strickler, J. H.
    Cohn, A. L.
    Arrowood, C.
    Haley, S.
    Morse, M.
    Uronis, H.
    Blobe, G. C.
    Hsu, S. D.
    Zafar, Y.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer
    Daniel J. Renouf
    Stephen Welch
    Malcolm J. Moore
    Monika K. Krzyzanowska
    Jennifer Knox
    Ronald Feld
    Geoffrey Liu
    Helen MacKay
    Jennifer Petronis
    Lisa Wang
    Eric Chen
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1339 - 1344
  • [5] A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer
    Renouf, Daniel J.
    Welch, Stephen
    Moore, Malcolm J.
    Krzyzanowska, Monika K.
    Knox, Jennifer
    Feld, Ronald
    Liu, Geoffrey
    MacKay, Helen
    Petronis, Jennifer
    Wang, Lisa
    Chen, Eric
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1339 - 1344
  • [6] A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group
    Hong, Yong Sang
    Lee, Sung Sook
    Kim, Kyu-pyo
    Lee, Jae-Lyun
    Kang, Yoon-Koo
    Shin, Sang Joon
    Ahn, Joong Bae
    Jung, Kyung Hae
    Im, Seock-Ah
    Kim, Tae-You
    Kim, Jee Hyun
    Park, Young Suk
    Kim, Tae Won
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 19 - 23
  • [7] A phase II study of oxaliplatin, capecitabine and bevacizumab in the treatment of metastatic colorectal cancer
    Hurwitz, H
    Fernando, N
    Yu, DH
    Morse, M
    Blobe, G
    Gockerman, J
    Odogwu, L
    Mahon, M
    Truax, R
    Franklin, A
    ANNALS OF ONCOLOGY, 2005, 16 : 285 - 285
  • [8] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metastatic or recurrent pancreatic cancer
    Sym, Sun Jin
    Hong, Junsik
    Jung, Minkyu
    Koo, Yang Seo
    Park, Yeon Ho
    Kim, Koen Kook
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dongbok
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer
    Wong, Nan Soon
    Fernando, Nishan H.
    Nixon, Andrew B.
    Cushman, Stephanie
    Aklilu, Mebea
    Bendell, Johanna C.
    Morse, Michael A.
    Blobe, Gerard C.
    Ashton, Jill
    Pang, Herbert
    Hurwitz, Herbert I.
    ANTICANCER RESEARCH, 2011, 31 (01) : 255 - 261
  • [10] Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer
    Bazarbashi, Shouki
    Aljubran, Ali
    Alzahrani, Ahmad
    Mohieldin, Ahmed
    Soudy, Hussein
    Shoukri, Mohammed
    CANCER MEDICINE, 2015, 4 (10): : 1505 - 1513
12345